FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419093920> ?p ?o ?g. }

• W2419093920 endingPage "1902" @default.
• W2419093920 startingPage "1895" @default.
• W2419093920 abstract "BACKGROUND Benign prostatic hyperplasia (BPH), a common disease in men over age 50 years, often causes bladder outlet obstruction and lower urinary tract symptoms (LUTS). Alpha blockers in combination with muscarinic receptor antagonists may have the potential to improve symptoms. This study aimed to assess the efficacy and safety of doxazosin or tamsulosin combined with tolterodine extend release (ER) in patients with BPH and LUTS. MATERIAL AND METHODS In a prospective, randomized, open-label study (ChiCTR-IPR-15005763), 220 consecutive men with BPH and LUTS were allocated to receive doxazosin 4 mg and tolterodine ER 4 mg per day (doxazosin group) or tamsulosin 0.2 mg and tolterodine ER 4 mg per day (tamsulosin group). Treatment lasted 12 weeks. The primary endpoint was the international prostatic symptom score (IPSS). Secondary endpoints were quality of life (QoL) and maximum flow rate (Qmax), which were evaluated at 0, 6, and 12 weeks, and urodynamic parameters assessed at 0 and 12 weeks. RESULTS A total of 192 patients completed the trial. Baseline measurements showed no differences between the groups. After 6 weeks, IPSS improved in both groups and QoL was significantly better in the doxazosin group (P=0.01). After 12 weeks, Qmax, IPSS, QoL, intravesical pressure (Pves), and bladder compliance (BC) in the doxazosin group were significantly better than in the tamsulosin group (P=0.03, P<0.001, P<0.001, P=0.027, and P=0.044, respectively). CONCLUSIONS Administration of alpha blockers combined with muscarinic receptor blocker for 12 weeks improved LUTS in men with BPH." @default.
• W2419093920 created "2016-06-24" @default.
• W2419093920 creator A5002931456 @default.
• W2419093920 creator A5024818901 @default.
• W2419093920 creator A5033185934 @default.
• W2419093920 creator A5043030184 @default.
• W2419093920 creator A5069327989 @default.
• W2419093920 creator A5071612651 @default.
• W2419093920 date "2016-06-04" @default.
• W2419093920 modified "2023-09-27" @default.
• W2419093920 title "A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia" @default.
• W2419093920 cites W1489169544 @default.
• W2419093920 cites W1495744231 @default.
• W2419093920 cites W1514921595 @default.
• W2419093920 cites W1524454035 @default.
• W2419093920 cites W1567909777 @default.
• W2419093920 cites W1596759229 @default.
• W2419093920 cites W1925228685 @default.
• W2419093920 cites W1947638799 @default.
• W2419093920 cites W1955636074 @default.
• W2419093920 cites W1967479412 @default.
• W2419093920 cites W1967694704 @default.
• W2419093920 cites W1970311061 @default.
• W2419093920 cites W1983094092 @default.
• W2419093920 cites W1991315347 @default.
• W2419093920 cites W1994569360 @default.
• W2419093920 cites W199786479 @default.
• W2419093920 cites W2012695517 @default.
• W2419093920 cites W2014040958 @default.
• W2419093920 cites W2022422644 @default.
• W2419093920 cites W2022805390 @default.
• W2419093920 cites W2031548942 @default.
• W2419093920 cites W2035539636 @default.
• W2419093920 cites W2051440758 @default.
• W2419093920 cites W2067551626 @default.
• W2419093920 cites W2072717707 @default.
• W2419093920 cites W2075773897 @default.
• W2419093920 cites W2089437227 @default.
• W2419093920 cites W2090839011 @default.
• W2419093920 cites W2119809361 @default.
• W2419093920 cites W2121759271 @default.
• W2419093920 cites W2127096827 @default.
• W2419093920 cites W2134121470 @default.
• W2419093920 cites W2147450987 @default.
• W2419093920 cites W2168290638 @default.
• W2419093920 cites W2286319201 @default.
• W2419093920 cites W2315566441 @default.
• W2419093920 cites W3144883685 @default.
• W2419093920 cites W423826136 @default.
• W2419093920 doi "https://doi.org/10.12659/msm.896283" @default.
• W2419093920 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4917326" @default.
• W2419093920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27260129" @default.
• W2419093920 hasPublicationYear "2016" @default.
• W2419093920 type Work @default.
• W2419093920 sameAs 2419093920 @default.
• W2419093920 citedByCount "8" @default.
• W2419093920 countsByYear W24190939202017 @default.
• W2419093920 countsByYear W24190939202018 @default.
• W2419093920 countsByYear W24190939202021 @default.
• W2419093920 countsByYear W24190939202022 @default.
• W2419093920 crossrefType "journal-article" @default.
• W2419093920 hasAuthorship W2419093920A5002931456 @default.
• W2419093920 hasAuthorship W2419093920A5024818901 @default.
• W2419093920 hasAuthorship W2419093920A5033185934 @default.
• W2419093920 hasAuthorship W2419093920A5043030184 @default.
• W2419093920 hasAuthorship W2419093920A5069327989 @default.
• W2419093920 hasAuthorship W2419093920A5071612651 @default.
• W2419093920 hasBestOaLocation W24190939202 @default.
• W2419093920 hasConcept C121608353 @default.
• W2419093920 hasConcept C126322002 @default.
• W2419093920 hasConcept C126894567 @default.
• W2419093920 hasConcept C142724271 @default.
• W2419093920 hasConcept C168563851 @default.
• W2419093920 hasConcept C204787440 @default.
• W2419093920 hasConcept C2776235491 @default.
• W2419093920 hasConcept C2776547966 @default.
• W2419093920 hasConcept C2777562237 @default.
• W2419093920 hasConcept C2777590997 @default.
• W2419093920 hasConcept C2778941218 @default.
• W2419093920 hasConcept C2779478474 @default.
• W2419093920 hasConcept C2780542891 @default.
• W2419093920 hasConcept C2781020410 @default.
• W2419093920 hasConcept C71924100 @default.
• W2419093920 hasConcept C84393581 @default.
• W2419093920 hasConceptScore W2419093920C121608353 @default.
• W2419093920 hasConceptScore W2419093920C126322002 @default.
• W2419093920 hasConceptScore W2419093920C126894567 @default.
• W2419093920 hasConceptScore W2419093920C142724271 @default.
• W2419093920 hasConceptScore W2419093920C168563851 @default.
• W2419093920 hasConceptScore W2419093920C204787440 @default.
• W2419093920 hasConceptScore W2419093920C2776235491 @default.
• W2419093920 hasConceptScore W2419093920C2776547966 @default.
• W2419093920 hasConceptScore W2419093920C2777562237 @default.
• W2419093920 hasConceptScore W2419093920C2777590997 @default.
• W2419093920 hasConceptScore W2419093920C2778941218 @default.
• W2419093920 hasConceptScore W2419093920C2779478474 @default.
• W2419093920 hasConceptScore W2419093920C2780542891 @default.
• W2419093920 hasConceptScore W2419093920C2781020410 @default.

• next